CDX肿瘤模型案例
Fig. In situ transplantation tumor model based on HepG2-Luc hepatocellular carcinoma cells (host mouse: M-NSG). a. Model tumourigenic curve versus body weight curve; b. Photograph of mouse liver; c. Mouse live imaging image.
Fig. Lung in situ graft tumour model constructed based on the human SHP-77-Luc lung cancer cell line.
Fig. Pancreatic in situ graft tumour model constructed based on the human PANC-1-Luc pancreatic cancer cell line.
Fig. Cervical transplantation in situ tumour model constructed based on the human Hela-Luc cervical cancer cell line.
Fig. In situ graft tumour model of glioma constructed based on the human U87MG glioma cell line.
Fig. Renal graft-in-situ tumor model constructed based on the human 786-O renal cancer cell line.
Fig. In situ transplant tumour model of bladder cancer constructed based on the human RT112-Luc bladder cancer cell line.
Fig. Femoral injection bone metastasis model constructed based on the human MDA-MB-231-Luc breast cancer cell line.
CDX肿瘤药效案例
Fig. Anti-tumour drug efficacy validation experiments using the CDX model of ovarian cancer cell line (SK-OV-3).
Fig. CAR-T cell therapy efficacy validation experiment using lung cancer cell line (A549) CDX model.
Fig. mRNA anti-tumor drug efficacy validation experiments using the CDX model of the B-lymphoblastic leukaemia cell line (Nalm6-Luc).
